MLICM
PRTK

Metropolitan Life Insurance Company (MetLife)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,212
Closed -$86.2K – 2918
2021
Q1 		$86.2K Sell
12,212
-2,280
-16% -$16.4K ﹤0.01% 2463
2020
Q4 		$90.7K Sell
14,492
-64
-0.4% -$377 ﹤0.01% 2401
2020
Q3 		$78.7K Sell
14,556
-272
-2% -$1.35K ﹤0.01% 2354
2020
Q2 		$77.4K Buy
+14,828
New +$65.9K ﹤0.01% 2397
2018
Q4 		– Sell
-14,760
Closed -$143K – 2583
2018
Q3 		$143K Hold
14,760
– – ﹤0.01% 2229
2018
Q2 		$151K Buy
14,760
+6,625
+81% +$75K ﹤0.01% 2112
2018
Q1 		$106K Hold
8,135
– – ﹤0.01% 2260
2017
Q4 		$146K Sell
8,135
-7,194
-47% -$150K ﹤0.01% 2093
2017
Q3 		$385K Hold
15,329
– – ﹤0.01% 1861
2017
Q2 		$369K Buy
15,329
+4,624
+43% +$102K ﹤0.01% 1919
2017
Q1 		$206K Hold
10,705
– – ﹤0.01% 2248
2016
Q4 		$165K Sell
10,705
-936
-8% -$12.2K ﹤0.01% 2461
2016
Q3 		$151K Buy
11,641
+1,028
+10% +$13.6K ﹤0.01% 2487
2016
Q2 		$148K Buy
10,613
+1,411
+15% +$20.8K ﹤0.01% 2527
2016
Q1 		$140K Hold
9,202
– – ﹤0.01% 2368
2015
Q4 		$175K Hold
9,202
– – ﹤0.01% 2345
2015
Q3 		$175K Hold
9,202
– – ﹤0.01% 2372
2015
Q2 		$237K Buy
+9,202
New +$261K ﹤0.01% 2286

Other funds holding PRTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PRTK Position: Q2 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 12,212 shares — an estimated $86.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRTK in Q2 2015 and held it in 18 quarters. The position peaked at $385K in Q3 2017. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 12,212 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $86.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 18 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Paratek Pharmaceuticals, Inc. position peaked at $385K in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.